MyStart Health Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.1/10
Best for: fastest compounded GLP-1 onboarding with a price lock
MyStart Health scores below our bar on medical oversight. Read the score breakdown before signing up.
Semaglutide
Tirzepatide
Price checked on MyStart Health's site,
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Included
Coaching
Not stated
No insurance needed · Vetted by our editors
MyStart Health offers compounded semaglutide and tirzepatide through a program that starts at $299/month, covering clinician visits, unlimited messaging, medication, any needed blood work and shipping. A price-lock guarantee keeps your base rate the same as your dose rises. Monthly and 3-month plans are available, and the site carries a LegitScript seal.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to MyStart Health
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
MyStart Health at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $299/mo (starting price)
- Pricing model
- Flat: dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping · Labs
- FDA status
- 1 FDA warning letter on record; see below
How we scored MyStart Health
Each dimension is scored algorithmically from MyStart Health'spublished pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
6.3/10MyStart Health's headline is $299/mo. Compare it with other programs on the same plan basis. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
8.5/10MyStart Health offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
8.2/10Online intake and platform experience (ongoing clinician messaging, consult included in the price); 6 platform features disclosed.
Trust & Safety15%
5.7/10Core details confirmed by our editors; an FDA warning letter is on file (see the regulatory notice on this page).
Accessibility10%
6.5/10MyStart Health's exact state footprint isn't published. Confirm coverage in your state before signing up.
Support10%
6.8/10Clinician messaging between visits.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this MyStart Health review
Last checked October 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $299/mo across 2 dose/plan tiers (checked October 2026)
- State pharmacy licensing & LegitScript status
- LegitScript Verified
- FDA warning-letter register
- An active letter is on file for this provider; see below
What to expect when you sign up with MyStart Health
We walked MyStart Health's public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Click 'Get Started' on the homepage; the site applies a SELFLOVE25 coupon code automatically.
- 2The intake form opens with a five-stage progress bar (Start, Preliminary, Health, Details, Eligibility).
- 3The first screen asks for your height and weight to calculate BMI.
- The homepage FAQ lists a $299/month starting price before you start the quiz, but the price for your specific plan comes later.
- Per the FAQ, payment is taken after the pre-qualification quiz and before a clinician reviews you, with a full refund in 24-48 hours if you are found ineligible.
- The intake page shows an 'Excellent 4.7' star badge with no source; the brand's Trustpilot profile shows 4.1 from about 326 reviews.
- Shipped orders are final: the refund policy rules out refunds or returns once medication ships.
- A Refill Intake Form is required every 3 months on any plan.
- Phone and email support hours are published on the site.
MyStart Health customer support
- Phone
- 888-828-5816
- Hours
- Monday-Friday 9am-7pm, Saturday 10am-4pm EST
GLP-1 medications MyStart Health offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Starts at $299/month before discounts, covering clinician visits, messaging, medication, any needed blood work and shipping. A $150 off + lifetime 25% off promo is advertised; final price shown after the quiz.
Same $299/month starting price and price lock as semaglutide. Per-drug plan prices are shown only after the health quiz.
Ready to get started?
Plans and promotions change often, so check MyStart Health's current pricing and active discounts before you decide.
What we like
- Price Lock Guarantee: your $299 base rate doesn't rise as your dose escalates
- Fast onboarding: roughly 5-minute intake, 24-hour prescription turnaround, 2–4 day shipping
- 24/7 care team access with unlimited clinician messaging included
- LegitScript certified
- Clear Section 503A compounding disclosure on every landing page
Watch-outs
- Not BBB accredited, and BBB complaints cite shipping delays and trouble reaching support
- Compounded only: no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
- Once medication ships, there are no refunds or returns under any circumstances
- Exact plan prices beyond the $299 starting rate appear only after the health quiz
- Very new company (incorporated May 2024) with a limited track record
- Pharmacy partners are not named, so you can't check them yourself
- Intake page shows an unsourced 'Excellent 4.7' badge, while Trustpilot shows 4.1
- Results claims rest on a survey of just 16 self-reporting customers
MyStart Health: built for speed, with a price lock as the hook
MyStart Health is a young, single-price GLP-1 service whose whole pitch is getting you started fast and never raising your bill. You pay $299 a month, that rate is locked even as your dose climbs, and you get semaglutide or tirzepatide in compounded form with everything bundled in. If your priority is near-instant onboarding and budget certainty, it fits. If you want a brand-name pen or a long, provable track record, it doesn't.
How the $299 flat price works
There are no dose tiers and no add-on invoices here. The single $299 monthly plan, per the company's own FAQ, covers physician evaluations, follow-up appointments, unlimited clinician messaging, your monthly prescription, a four-week or twelve-week supply of medication depending on the plan you pick, any necessary blood work, and shipping. MyStart also states your base plan amount will never increase even when your dosage goes up, though the lock excludes the first-time discount, and the exact price for your plan appears only after the health quiz. With most compounders, your cost climbs every time you titrate to a higher dose, so a rate that holds flat through escalation protects you from that climb.
The category median runs closer to $179 a month, so $299 is on the higher side of compounded pricing. You're paying a premium for the all-in bundle and the locked rate. Whether that trade is worth it depends on how much you value never getting a surprise bill as your dose ramps up.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 129 programs that publish one.
The medications: compounded only
MyStart dispenses compounded semaglutide and tirzepatide under Section 503A, and to its credit it posts a clear disclosure on its landing pages stating these compounded medications are not FDA-approved and not evaluated by the FDA for safety, effectiveness, or quality. Many rivals disclose less. The flip side is that no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro is available through this provider. MyStart sells the standard weekly injections; we found no oral tirzepatide on the current site. A tablet is where SurpassMD stands out: it offers an oral semaglutide plan at one price for every dose and serves all 50 states plus DC, but it doesn't name its pharmacy.
Onboarding speed
MyStart advertises a roughly five-minute intake, a prescription turnaround inside about 24 hours, and two-to-four-day shipping. Paired with 24/7 care-team access and unlimited clinician messaging, the experience is designed to move you from sign-up to medication in your hands faster than most competitors. For someone who has already decided they want to start a GLP-1 and just wants the path of least friction, that speed is MyStart's main selling point.
- Price-lock guarantee: your $299 base rate doesn't rise as your dose escalates
- About a five-minute intake, ~24-hour prescription turnaround, and two-to-four-day shipping
- Consults, follow-ups, unlimited messaging, labs, and shipping are all in the one price
- LegitScript certified, with a clear 503A compounding disclosure on each landing page
Who runs it, and what it discloses
The legal entity is MyStart Health LLC, a Delaware management services organization that partners with licensed US clinicians. It was incorporated in May 2024, with Matthew Stern listed as founder and CEO and Dr. Ritu Chopra as chief medical advisor. On the trust side, the site carries a LegitScript seal, but the company has an FDA warning letter on file (September 2025, for selling unapproved and misbranded drugs online), covered in the regulatory notice on this page.
The gaps are about youth and disclosure. The company has been operating only since 2024, so there's little long-term track record to lean on. It is not BBB accredited, and its BBB complaints center on shipping delays and difficulty reaching support, which sits awkwardly next to the marketing emphasis on 24/7 access. Trustpilot shows about 4.1 out of 5 from roughly 326 reviews, while the intake page displays an "Excellent 4.7" badge with no source given. And the pharmacy partners aren't publicly named, which means a reader can't independently confirm the 503A compliance chain. Compare Tell Her Doc, which lists four partner pharmacies and its medical team, with injections or pills built for women, but its sales are final too. The efficacy numbers on the homepage also rest on a self-reported survey of just sixteen customers, which is far too small to treat as evidence of how well the program works. Finally, read the refund policy before you pay: once an order ships, it cannot be canceled or refunded under any circumstances, and returned medication is never accepted. You can cancel future shipments at any time by email or phone.
Who should choose it, and who should skip it
Choose MyStart Health if you want to start quickly, you value a locked-in monthly cost as you titrate up, and you're comfortable with compounded medication and a newer company. The flat $299 bundle is easy to reason about and protects you from dose-driven price creep.
Skip it if you want a brand-name GLP-1. Skip it if a company founded in 2024 with an unaccredited BBB profile and a strict no-refund-after-shipping policy gives you pause. And skip it if you want the lowest possible price, since the category median sits well below $299. Cross-check it against a couple of cheaper compounders using our scoring methodology before you commit.
Bottom line
MyStart Health sells speed and a fixed bill: fast onboarding, unlimited access, and a price lock that holds your $299 rate steady through every dose increase. It has LegitScript certification and an upfront compounding disclosure. On the other side, it's compounded-only, young, not BBB accredited, leans on a tiny efficacy survey, and refunds nothing once medication ships. If you care more about a quick start and a predictable bill than about the cheapest price or a brand-name pen, it's a credible choice you should still vet against a lower-cost alternative.
The Bottom Line
MyStart Health scores below our bar on medical oversight. Read the score breakdown before signing up.
Ready to start with MyStart Health?
From $299/mo. See current pricing and start your online intake.
MyStart Health might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare MyStart Health vs…
MyStart Health scores7.1/10
Side-by-side pricing, medications and scores. Pick a matchup.
MyStart Health vs Amazon One Medical
Amazon One Medical scores 8.5/10

MyStart Health vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Regulatory notice
MyStart Health received an FDA warning letter dated September 9, 2025
The letter concerns unlawful sale of unapproved and misbranded drugs to United States consumers over the internet (telehealth). FDA warning letters are public regulatory communications and do not, on their own, constitute a finding of illegal activity. Companies often respond with corrective action.
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this MyStart Health review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 4.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See MyStart Health's current pricing
Plans from $299/mo. Start the online intake to check eligibility and today's price.